AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21638755
Drug: Deferasirox treatment
RxNorm normalized name: Deferasirox
DrugBank: Deferasirox (DB01609)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Deferasirox treatment (25 mg/kg/day)
Trial: 21638755
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no iron chelation treatment)
Trial: 17196682
Drug: Nicorandil (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (4 mg)
Trial: 15190527
Drug: CSD implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSD implant plus optimal medical therapy
Trial: 7653770
Drug: Droperidol 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 1.25 mg intravenously 20 min prior to the end of surgery and a patient‐controlled analgesia infusion containing morphine 1 mg.ml‐1 and droperidol 0.05 mg.ml‐1
Trial: 7653770
Drug: Cyclizine 50
RxNorm normalized name: cyclizine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclizine 50 mg by slow intravenous injection 20 min prior to the end of surgery and a patient‐controlled analgesia infusion containing morphine 1 mg.ml‐1 and cyclizine 2 mg.ml‐1
Trial: 338024
Drug: Oestradiol, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestradiol, 2 mg
Trial: 338024
Drug: Oestriol, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestriol, 1 mg
Trial: 29154060
Drug: Cholesfytol® (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesfytol® (1 tablet/day)
Trial: 23077975
Drug: True RH
RxNorm normalized name: anti-D (rh) immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: True RH (elevated awake or asleep SBP/DBP means while treated with 3 medications, or any patient treated with ≥4 medications)
Trial: 20573655
Drug: Naloxone (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (IV injection of two 0.4 mg ampules)
Trial: 16533781
Drug: 1,200 mg
RxNorm normalized name: lecithin 1,200 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,200 mg orally once daily (arm A)
Trial: 16533781
Drug: 1,200 mg
RxNorm normalized name: lecithin 1,200 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,200 mg orally twice daily (arm B)
Trial: 8463435
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 60 mg diltiazem
Trial: 8463435
Drug: Diltiazem 60
RxNorm normalized name: DILTIAZEM 60MG 12HR CAP,SA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 60 mg three times a day for 3 days
Trial: 8463435
Drug: Diltiazem 60
RxNorm normalized name: DILTIAZEM 60MG 12HR CAP,SA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 60 mg three times a day for 6 days
Trial: 18313127
Drug: Aspirin 75
RxNorm normalized name: aspirin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 75 mg/d
Trial: 26661570
Drug: Intravenous neostigmine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous neostigmine (0.5 mg)
Trial: 8442622
Drug: Nurse-assisted combination
RxNorm normalized name: PAD,NURSING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-assisted combination of self-quit training and referral
Trial: 29175067
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist protocol (528 women)
Trial: 29175067
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist protocol (495 women)
Trial: 22388491
Drug: Caffeine supplementation
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine supplementation (doses of 2, 4, 6, 8, and 10 mg·kg bm(‐1))
Trial: 18508290
Drug: Satavaptan 5
RxNorm normalized name: Satavaptan
DrugBank: Satavaptan (DB14923)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Satavaptan 5 mg once daily
Trial: 18508290
Drug: Satavaptan 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Satavaptan 12.5 mg once daily
Trial: 18508290
Drug: Satavaptan 25
RxNorm normalized name: Satavaptan
DrugBank: Satavaptan (DB14923)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Satavaptan 25 mg once daily
Trial: 17262795
Drug: Imatinib mesylate
RxNorm normalized name: Imatinib Mesylate
DrugBank: Imatinib (DB00619)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Imatinib mesylate at a dose of 440 mg/m²/day for 28 days
Trial: 10770462
Drug: Lorazepam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (0.5 mg twice daily)
Trial: 10163609
Drug: Metered-Dose Inhaler
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered-Dose Inhaler (MDI)
Trial: 16388832
Drug: Hydrocortisone 100
RxNorm normalized name: hydrocortisone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone 100 mg
Trial: 22051940
Drug: Basic Plus
RxNorm normalized name: Casanthranol/Docusate Sodium 30 MG-100 MG Oral Capsule, Liquid Filled [LAXA-BASIC PLUS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic Plus (n = 137) - PCP counseling every 4 months plus monthly LC visits during the first year of treatment
Trial: 20613460
Drug: Salsalate (anti-inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salsalate (anti-inflammatory treatment)
Trial: 17663101
Drug: Acupoint-injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint-injection of BCG polysaccharide nuclear acid (BCG-PSN)
Trial: 17663101
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of BCG-PSN
Trial: 17663101
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of interferon
Trial: 17663101
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (blank control group)
Trial: 16105152
Drug: Sotalol 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol 100 mg
Trial: 16105152
Drug: Lignocaine 100
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine 100 mg
Trial: 12139216
Drug: Nitazoxanide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitazoxanide (200 mg for 3 days)
Trial: 12139216
Drug: Quinfamide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinfamide (100 mg for 1 day), mebendazole (200 mg for 3 days), or both
Trial: 10199534
Drug: Methylprednisolone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (30 mg/kg) before cardiopulmonary bypass and before declamping of the aorta (MPS group, n = 11)
Trial: 437665
Drug: Actovegin forte
RxNorm normalized name: Erythroped Forte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actovegin forte dragées, 2 dragées three times daily for six weeks
Trial: 30597025
Drug: High-dose rifampicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose rifampicin (35 mg/kg)
Trial: 30597025
Drug: Standard rifampicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard rifampicin (10 mg/kg daily)
Trial: 14600809
Drug: Heparin anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin anticoagulation
Trial: 16882889
Drug: Eccentric strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eccentric strength training (squats on a 25 degrees decline board, 3 sets of 15 repetitions, twice daily for 12 weeks)
Trial: 16882889
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (open patellar tenotomy with rehabilitation)
Trial: 11748758
Drug: acute levodopa
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: acute levodopa (L-dopa) challenge
Trial: 9269364
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg suppository diclofenac before surgical incision and morphine infusion 1.5 mg per hour postoperatively
Trial: 9269364
Drug: Morphine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine infusion 1.5 mg per hour postoperatively
Trial: 8111804
Drug: Diltiazem 90
RxNorm normalized name: diltiazem 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 90 mg BID
Trial: 8111804
Drug: Diltiazem 180
RxNorm normalized name: diltiazem 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 180 mg BID
Trial: 27100753
Drug: 450 cc
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 450 cc blood donation
Trial: 24026316
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg of methylprednisolone
Trial: 24026316
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of methylprednisolone
Trial: 18042410
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg ASU
Trial: 11834948
Drug: Genotypic resistance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genotypic resistance information (G)
Trial: 7570257
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Laser and Ultrasounds
Trial: 2287048
Drug: Non-supervised home
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-supervised home exercise program (2 km walk-jog exercise daily for 1 month, HR at 90-100% of anaerobic threshold)
Trial: 10782805
Drug: Infliximab (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (10 mg/kg)
Trial: 30840903
Drug: Second intravenous
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second intravenous immunoglobulin (IVIG) (2 g/kg)
Trial: 30927252
Drug: HIV-positive children
RxNorm normalized name: Pediaclear Childrens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV-positive children on antiretroviral therapy (ART)
Trial: 30927252
Drug: HIV-positive children
RxNorm normalized name: Pediaclear Childrens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV-positive children with nevirapine treatment
Trial: 27859546
Drug: Bimekizumab (8-640
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimekizumab (8-640 mg)
Trial: 27859546
Drug: Bimekizumab (160-640
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimekizumab (160-640 mg)
Trial: 27859546
Drug: Bimekizumab (≥160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimekizumab (≥160 mg)
Trial: 23867729
Drug: Nerve growth
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nerve growth factor (NGF) injections
Trial: 12753335
Drug: IFN/Riba and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN/Riba and amantadine (Ama) including a 2‐week initial high IFN induction course (18 MU IFN daily) (group A)
Trial: 8511862
Drug: Cryotherapy (CT)
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryotherapy (CT) in combination with therapeutic exercise
Trial: 8511862
Drug: Cryoelectrotherapy (CET)
RxNorm normalized name: CET
DrugBank: Cefalotin (DB00456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cryoelectrotherapy (CET) in combination with therapeutic exercise
Trial: 27613466
Drug: S0597 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S0597 50 μg
Trial: 27613466
Drug: S0597 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S0597 200 μg
Trial: 27613466
Drug: S0597 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S0597 400 μg
Trial: 18155534
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa (EPO) dose
Trial: 16846409
Drug: Aprotinin (500,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprotinin (500,000 KIU) administered in two equal doses (before skin incision and added to the pump prime)
Trial: 12848279
Drug: n-3 FA
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 FA (fermented soybean milk with fish oil containing 600 mg of EPA and 260 mg of DHA/d for 12 weeks)
Trial: 9738550
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (delayed-treatment)
Trial: 21602313
Drug: Metreleptin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metreleptin (10 mg/day self-injected s.c.)
Trial: 7650958
Drug: Electric acupuncture
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electric acupuncture treatment
Trial: 7650958
Drug: Supportive medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive medication (Control)
Trial: 25682232
Drug: Tiotropium 2.5
RxNorm normalized name: TIOTROPIUM 2.5MCG/ACTUAT 60D ORAL INHL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 2.5 μg
Trial: 25694383
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist treatment (goserelin, 3.6 mg) starting 3-5 days postoperatively (Group O)
Trial: 25694383
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist treatment (goserelin, 3.6 mg) starting on days 1-5 of menstruation (Group M)
Trial: 25694383
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist treatment (Group M)
Trial: 25694383
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist treatment (Group O)
Trial: 19889154
Drug: Cyclic photodynamic
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic photodynamic therapy (PDT) treatments at 4- to 8-week intervals for 2 years.
Trial: 18594748
Drug: Crenotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crenotherapy treatment (vapour inhalation, aerosol and nasal douching) with thermal water for 14 days
Trial: 18594748
Drug: Nasal douching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal douching and aerosol with saline twice a day for 14 days
Trial: 18594748
Drug: Crenotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crenotherapy treatment with thermal water
Trial: 12885707
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (AA) from limeade, 25 mg consumed with each of 2 daily meals, 500 mL limeade twice a day, 6 days/week for 8 months
Trial: 8630579
Drug: 1,000 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 micrograms of inhaled beclomethasone daily for 1 yr
Trial: 21107432
Drug: Olmesartan 20
RxNorm normalized name: olmesartan 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan 20 mg/Amlodipine 5 mg
Trial: 21107432
Drug: Olmesartan 20
RxNorm normalized name: olmesartan 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan 20 mg/Hydrochlorothiazide 12.5 mg
Trial: 17439538
Drug: Diazepam 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 30 mg intrarectal gel
Trial: 10691230
Drug: PCA (patient-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA (patient-controlled analgesia) with intravenous morphine
Trial: 8458180
Drug: 5 x
RxNorm normalized name: PAD,ABDOMINAL 5 X 9 STERILE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 x 2.5 mg levoleucovorin tablets
Trial: 8458180
Drug: 5 x
RxNorm normalized name: PAD,ABDOMINAL 5 X 9 STERILE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 x 5 mg leucovorin tablets
Trial: 8458180
Drug: 1 x
RxNorm normalized name: Black Cohosh 1 X Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 x 12.5 mg levoleucovorin tablet
Trial: 8458180
Drug: 1 x
RxNorm normalized name: Black Cohosh 1 X Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 x 25 mg leucovorin tablet
Trial: 8458180
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg levoleucovorin injection
Trial: 8458180
Drug: 2 x
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 x 7.5 mg levoleucovorin tablets
Trial: 8458180
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg leucovorin injection
Trial: 8458180
Drug: 2 x
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 x 15 mg leucovorin tablets
Trial: 26104969
Drug: β-blocker bisoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-blocker bisoprolol 5mg qd
Trial: 27774730
Drug: In-center daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-center daily hemodialysis (6 days/week)
Trial: 18362486
Drug: Fluoxetine 90
RxNorm normalized name: fluoxetine 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 90 mg plus Tadalafil 20 mg
Trial: 18362486
Drug: Fluoxetine 90
RxNorm normalized name: fluoxetine 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 90 mg
Trial: 15809403
Drug: Haloperidol (2-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (2-20 mg/d)
Trial: 10216796
Drug: Blood pressure
RxNorm normalized name: Blood Pressure Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood pressure control and angiotensin-converting enzyme (ACE) inhibitors
Trial: 10216796
Drug: Treatment of
RxNorm normalized name: DRUGS FOR TREATMENT OF LEPRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment of hyperlipidemia
Trial: 431401
Drug: C+G (Carbenicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C+G (Carbenicillin + Gentamicin)
Trial: 431401
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (C+A, C+G, C+S)
Trial: 29749328
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin E (400 mg/day)
Trial: 29749328
Drug: Oral UDCA
RxNorm normalized name: UDCA
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral UDCA (15 mg/kg/day)
Trial: 29749328
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of vitamin E and UDCA
Trial: 29749328
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no drug except chemotherapy)
Trial: 22252804
Drug: Dihydroartemisinin-piperaquine monthly
RxNorm normalized name: .alpha.-dihydroartemisinin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroartemisinin-piperaquine monthly (DPm)
Trial: 15653941
Drug: Fluoxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20 mg‐60 mg/day)
Trial: 9818845
Drug: Diastat (diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diastat (diazepam rectal gel)
Trial: 7656471
Drug: L-fucose in
RxNorm normalized name: L-FUCOSE
DrugBank: Fucose (DB15236)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-fucose in RA patients
Trial: 786422
Drug: Flurbiprofen 150
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 150 mg daily for 5 days
Trial: 786422
Drug: Soluble aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble aspirin 3.6 g daily for 5 days
Trial: 6773484
Drug: Parenteral amino
RxNorm normalized name: parenteral amino acid 7 % comb no.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral amino acids
Trial: 22215654
Drug: Intravenous glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glucose (delivered intragastrically)
Trial: 16079222
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion (3 kcal/min)
Trial: 21284343
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of arginine (20 g per day)
Trial: 16274036
Drug: Perioperative nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative nutrition support (enteral and parenteral nutrition)
Trial: 16274036
Drug: Routine postoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Routine postoperative parenteral nutrition
Trial: 16274036
Drug: Perioperative nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative nutrition support (enteral and parenteral nutrition) in PD subgroup
Trial: 16274036
Drug: Routine postoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Routine postoperative parenteral nutrition in PD subgroup
Trial: 11964588
Drug: Dexamethasone 1
RxNorm normalized name: dexamethasone 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 1 mg/kg-1 after induction of anesthesia